GCMCX
Price
$29.89
Change
+$0.15 (+0.50%)
Updated
Oct 17 closing price
Net Assets
1.09B
VIMAX
Price
$358.27
Change
+$0.63 (+0.18%)
Updated
Oct 17 closing price
Net Assets
201.28B
Interact to see
Advertisement

GCMCX vs VIMAX

Header iconGCMCX vs VIMAX Comparison
Open Charts GCMCX vs VIMAXBanner chart's image
Goldman Sachs Mid Cap Value C
Price$29.89
Change+$0.15 (+0.50%)
VolumeN/A
Net Assets1.09B
Vanguard Mid Cap Index Admiral
Price$358.27
Change+$0.63 (+0.18%)
VolumeN/A
Net Assets201.28B
GCMCX vs VIMAX Comparison Chart in %
View a ticker or compare two or three
VS
GCMCX vs. VIMAX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCMCX is a StrongBuy and VIMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 201B vs. GCMCX (1.09B). VIMAX pays higher dividends than GCMCX: VIMAX (1.48) vs GCMCX (0.18). GCMCX was incepted earlier than VIMAX: GCMCX (28 years) vs VIMAX (24 years). GCMCX (1.95) is less costly to investors than VIMAX (0.05). GCMCX is a more actively managed with annual turnover of: 56.00 vs. VIMAX (16.00). GCMCX has a lower initial minimum investment than VIMAX: GCMCX (1000) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 7.58 vs. GCMCX (-5.10). VIMAX return over 5 years is better than : 57.32 vs. GCMCX (6.86).
GCMCXVIMAXGCMCX / VIMAX
Total Expense Ratio1.940.053,880%
Annual Report Gross Expense Ratio1.950.053,900%
Fund Existence28 years24 years-
Gain YTD5.4699.70756%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.09B201B1%
Annual Yield % from dividends0.181.4813%
Returns for 1 year-5.107.58-67%
Returns for 3 years4.0349.708%
Returns for 5 years6.8657.3212%
Returns for 10 years-15.84140.93-11%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVX1.980.02
+1.02%
NOVONIX Limited
CXM7.620.05
+0.66%
Sprinklr
ABVC2.92N/A
N/A
ABVC BioPharma
ATIIU10.59N/A
N/A
Archimedes Tech SPAC Partners II Co
MDGL438.90-3.23
-0.73%
Madrigal Pharmaceuticals